Form 8-K - Current report:
SEC Accession No. 0000950170-24-127560
Filing Date
2024-11-15
Accepted
2024-11-15 16:03:36
Documents
12
Period of Report
2024-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20241108.htm   iXBRL 8-K 43073
2 EX-10.1 acet-ex10_1.htm EX-10.1 47436
  Complete submission text file 0000950170-24-127560.txt   213427

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20241108.xsd EX-101.SCH 25038
15 EXTRACTED XBRL INSTANCE DOCUMENT acet-20241108_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 241467745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)